Carl C. Dockery's most recent trade in Aytu BioPharma Inc was a trade of 10,000 Common Stock done . Disclosure was reported to the exchange on July 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aytu BioPharma Inc | Carl C. Dockery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2026 | 10,000 | 31,152 (0%) | 0% | 0 | Common Stock | |
| Aytu BioPharma Inc | Carl C. Dockery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 10,000 | 20,440 (0%) | 0% | 0 | Common Stock | |
| Aytu BioPharma Inc | Carl C. Dockery | Director | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 30 Jun 2025 | 10,000 | 50 (0%) | 0% | 0.9 | 9,230 | Common Shares |
| Aytu BioPharma Inc | Carl C. Dockery | Director | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 30 Jun 2025 | 209 | 0 (0%) | 0% | 6.0 | 1,256 | Common Shares |
| Aytu BioPharma Inc | Carl C. Dockery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 1,500 | 10,440 (0%) | 0% | 0 | Common Shares | |
| Aytu BioPharma Inc | Carl C. Dockery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 1,500 | 8,940 (0%) | 0% | 0 | Common Shares |